Abstract
The robust host responses elicited against transgenes encoded by E1 -E3- adenovirus (Ad) gene transfer vectors can be used to develop Ad-based vectors as platform technologies for vaccines against potential bioterror pathogens. This review focuses on pathogens of major concern as bioterror agents and why Ad vectors are ideal as anti-bioterror vaccine platforms, providing examples from our laboratories of using Ad vectors as vaccines against potential bioterror pathogens and how Ad vectors can be developed to enhance vaccine efficacy in the bioterror war.
Original language | English (US) |
---|---|
Pages (from-to) | 157-168 |
Number of pages | 12 |
Journal | Human Gene Therapy |
Volume | 16 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2005 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology
- Genetics